• About us
    • Profile
    • Board of Directors
    • Scientific Directors
  • Our Science
    • Strategy
    • Activities and Technologies
  • Pipeline
    • Pipeline
    • OncoFAP-Radio Conjugate
    • OncoFAP-Drug Conjugate
    • Onco IX (PHC-102, Imaging)
  • Press releases & Events
  • Work with us
    • Careers
    • Industrial Ph.D. Program
    • Partnering
  • About us
    • Profile
    • Board of Directors
    • Scientific Directors
  • Our Science
    • Strategy
    • Activities and Technologies
  • Pipeline
    • Pipeline
    • Onco IX (PHC-102, Imaging)
    • OncoFAP-Radio Conjugate
    • OncoFAP-Drug Conjugate
  • Press releases & Events
  • Work with us
    • Careers
    • Industrial Ph.D. Program
    • Partnering

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

by mfantozzi | Nov 24, 2021 | 2021, Press Releases, Scientific

More datails

Philogen Q3 2021 Virtual Briefing

by last | Nov 15, 2021 | 2021, Investors, Past Events

Listen to Webcast

Philogen provides Corporate Update

by mfantozzi | Nov 12, 2021 | 2021, Press Releases, Scientific

Philogen to hold a Webinar at 11 am EST / 4 pm GMT / 5 pm CET on Friday 12th November 2021, Click here to view Press Release 12-11-2021

Philogen together with the University of Zürich to participate at the 26th Annual Meeting & Education of the Society for Neuro-Oncology on November 18-21, 2021

by last | Nov 8, 2021 | 2021, Past Events

Dr. Tobias Weiss, the Principal Investigator of Fibromun’s programs in brain tumors, is presenting an ePoster entitled “Lomustine and targeted-cytokine therapy: a beneficial liaison for recurrent glioblastoma

Philogen to attend the Connective Tissue Oncology Society (CTOS) Virtual 2021 Annual Meeting on November 10-13, 2021

by last | Nov 7, 2021 | 2021, Past Events

Philogen is presenting a ePoster on the results of the run-in part of the Phase II study with Fibromun plus Dacarbazine for patients with in third or later line advanced/metastatic soft tissue sarcoma. See here for more details.

Philogen to Attend the Festival of Biologics Basel on November 10, 2021

by last | Nov 6, 2021 | 2021, Past Events

Philogen announces its attendance at the Festival of Biologics Basel on November 10, 2021 Lisa Nadal, 3-year PhD student at Philogen, is giving a lecture entitled “A novel IL12-based immunocytokine targeting Fibroblast Activation Protein (FAP) for the treatment...
« Older Entries

Recent Posts

  • Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)
  • Philogen to attend the Society for Immunotherapy of Cancer’s 37th Annual Meeting 2022 in Boston (8-12 November 2022)
  • Philochem will be attending the 10th World ADC Conference in London
  • Philogen announces the publication of a new study in the European Journal of Nuclear Medicine and Molecular Imaging
  • Philogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands

Recent Comments

    Philochem AG ©

    Privacy / Contacts

    • Follow

    Philochem AG | Libernstrasse 3 | CH-8112 | Otelfingen – Switzerand |MWST-Nr/VAT-REG: CHE-113.181.443 | Registration Nr. CH-020.3.030.226-7 Ph. (+41) 43 544 88 00 | Fax (+41) 43 544 88 09| info@philochem.ch